Literature DB >> 21076743

Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2].

Luca Ronconi1, Peter J Sadler.   

Abstract

The photodecomposition of the anticancer complex trans,trans,trans-[Pt(N(3))(2)(OH)(2)(NH(3))(2)] in acidic aqueous solution, as well as in phosphate-buffered saline (PBS), induced by UVA light (centred at λ = 365 nm) has been studied by multinuclear NMR spectroscopy. We show that the photoreaction pathway in PBS, which involves azide release, differs from that in acidic aqueous conditions, under which N(2) is a major product. In both cases, a number of trans-{N-Pt(II/IV)-NH(3)} species were also observed as photoproducts, as well as the evolution of O(2) and release of free ammonia with a subsequent increase in pH. The results from this study illustrate that photoinduced reactions of Pt(IV)-diazido derivatives can lead to novel reaction pathways, and therefore potentially to new cytotoxic mechanisms in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076743     DOI: 10.1039/c0dt00546k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  11 in total

1.  [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.

Authors:  Robert N Garner; Judith C Gallucci; Kim R Dunbar; Claudia Turro
Journal:  Inorg Chem       Date:  2011-08-31       Impact factor: 5.165

Review 2.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

3.  Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism.

Authors:  Aron F Westendorf; Julie A Woods; Katharina Korpis; Nicola J Farrer; Luca Salassa; Kim Robinson; Virginia Appleyard; Karen Murray; Renate Grünert; Alastair M Thompson; Peter J Sadler; Patrick J Bednarski
Journal:  Mol Cancer Ther       Date:  2012-06-18       Impact factor: 6.261

4.  Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study.

Authors:  Hanlu Wang; Nathan J DeYonker; Xiting Zhang; Cunyuan Zhao; Liangnian Ji; Zong-Wan Mao
Journal:  J Mol Model       Date:  2012-06-01       Impact factor: 1.810

5.  Acetate-bridged platinum(III) complexes derived from cisplatin.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2012-09-04       Impact factor: 5.165

6.  Insights into the acid-base properties of Pt(IV)-diazidodiam(m)inedihyroxido complexes from multinuclear NMR spectroscopy.

Authors:  Luca Ronconi; Ana M Pizarro; Ruth J McQuitty; Peter J Sadler
Journal:  Chemistry       Date:  2011-09-16       Impact factor: 5.236

7.  Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor.

Authors:  Shuting Xu; Xinyuan Zhu; Chuan Zhang; Wei Huang; Yongfeng Zhou; Deyue Yan
Journal:  Nat Commun       Date:  2018-05-24       Impact factor: 14.919

Review 8.  New Designs for Phototherapeutic Transition Metal Complexes.

Authors:  Cinzia Imberti; Pingyu Zhang; Huaiyi Huang; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-24       Impact factor: 16.823

9.  DFT Study on the Substituent Effect of Anticancer Picoline-Diazido-Pt(IV) Compounds.

Authors:  Meilin Mu; Hongwei Gao
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

10.  Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.

Authors:  Yao Zhao; Julie A Woods; Nicola J Farrer; Kim S Robinson; Jitka Pracharova; Jana Kasparkova; Olga Novakova; Huilin Li; Luca Salassa; Ana M Pizarro; Guy J Clarkson; Lijiang Song; Viktor Brabec; Peter J Sadler
Journal:  Chemistry       Date:  2013-06-03       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.